EN
HI
Glaxosmithkline Pharmaceuticals Chart
Glaxosmithkline Pharmaceuticals Share Key Metrics
Volume
80193.00
Market Cap
39756.21 CR
LTQ@LTP
26@2346.80
ATP
2361.2
Var Margin
15.87 %
Circuit Range
1911.6-2867.2
Delivery %
57.2 %
Value
18.94 CR
ASM/GSM
No
Market Lot
1
Summary
Glaxosmithkline Pharmaceuticals share price is ₹2346.8 as of 21 May, 2026. The stock Glaxosmithkline Pharmaceuticals intraday movement has stayed between ₹2340.10 and ₹2397.80, while on a 52-week basis,Glaxosmithkline Pharmaceuticals price 52 week high is ₹3515.70 & its 52 week low is ₹2217.60.
In terms of trading activity, Glaxosmithkline Pharmaceuticals has recorded a volume of 80193 shares, The Glaxosmithkline Pharmaceuticals has a market cap of ₹169406034 CR. The stock’s Average Traded Price (ATP) stands at ₹2361.20, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 26 @ ₹2346.80.
Glaxosmithkline Pharmaceuticals operates within a circuit range of ₹1911.60 – ₹2867.20, with a Value of ₹18.94 CR. The Delivery Percentage for the day is 57.2%. Additionally, Glaxosmithkline Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1.
Glaxosmithkline Pharmaceuticals Fundamentals
View MoreP/E Ratio
39.06
P/B Ratio
17.85
Div. Yield
2.39
Sector P/E
71.7
Sector P/B
3.51
Sec. Div. Yield
0.56
Glaxosmithkline Pharmaceuticals Resistance and Support
Pivot 2396.4
Resistance
First Resistance
2415.6
Second Resistance
2441.8
Third Resistance
2461
Support
First Support
2370.2
Second Support
2351
Third Support
2324.8
Glaxosmithkline Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-13 | Audited Results & Dividend |
| 2026-02-09 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-08-01 | Quarterly Results |
| 2025-05-13 | Audited Results & Final Dividend |
| 2025-02-14 | Quarterly Results |
| 2025-02-10 | Quarterly Results |
Glaxosmithkline Pharmaceuticals News
GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Glaxosmithkline Pharmaceuticals held its Q4 FY26 and full year earnings call. The company reported full year revenue growth of 2% and net profit growth of 10%, with cash position at Rs.2,745 crores. Management discussed positive outlook for new products, ongoing supply chain normalization, and strategies for continued margin expansion.
May 18 2026 13:05:00
GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
GlaxoSmithKline Pharmaceuticals has uploaded the audio and video recordings of its analyst and institutional investor meetings to its website. This ensures compliance with disclosure requirements and provides stakeholders access to the meeting content.
May 13 2026 19:05:00
Read More
About Glaxosmithkline Pharmaceuticals
NSE : 1153
BSE : 500660
ISIN : INE159A01016
Glaxosmithkline Pharmaceuticals Management
| Name | Position |
|---|---|
| Ajay Nadkarni | Company Secretary & Compliance Officer, Vice President – Administration, Real Estate |
| Renu Sud Karnad | Chairperson |
Glaxosmithkline Pharmaceuticals Similar Stocks
Glenmark Pharmaceuticals Ltd.
2379.00
-26.90 (1.12%)
Alkem Laboratories Ltd.
5436.50
-33.50 (0.61%)
Abbott India Ltd.
27445.00
-350.00 (1.26%)
Anthem Biosciences Ltd.
780.50
-6.85 (0.87%)
Ipca Laboratories Ltd.
1646.60
-9.60 (0.58%)
Ajanta Pharma Ltd.
3188.80
-59.40 (1.83%)
Aster DM Healthcare Ltd.
764.85
15.95 (2.13%)
Narayana Hrudayalaya Ltd.
1902.40
18.30 (0.97%)
Gland Pharma Ltd.
2221.80
-29.30 (1.30%)
JB Chemicals & Pharmaceuticals Ltd.
2163.60
-8.00 (0.37%)
Glaxosmithkline Pharmaceuticals FAQs
The Buying Price of Glaxosmithkline Pharmaceuticals share is 2346.8 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Glaxosmithkline Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Glaxosmithkline Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Glaxosmithkline Pharmaceuticals shares is 39.06. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Glaxosmithkline Pharmaceuticals shares is 17.85. Useful to assess the stock's value relative to its book value.
To assess Glaxosmithkline Pharmaceuticals’s valuation compare Sector P/E, P/B which are 71.7 & 3.51 with sector averages, along with growth rates and financial metrics.
The Market Cap of Glaxosmithkline Pharmaceuticals is 39756.21 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Glaxosmithkline Pharmaceuticals share price is 3515.70 & 2217.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Glaxosmithkline Pharmaceuticals belongs to the Healthcare sector.
